NO996467D0 - Fremgangsmåte for fremstilling av tiazofurin og andre C- nukleosider - Google Patents

Fremgangsmåte for fremstilling av tiazofurin og andre C- nukleosider

Info

Publication number
NO996467D0
NO996467D0 NO996467A NO996467A NO996467D0 NO 996467 D0 NO996467 D0 NO 996467D0 NO 996467 A NO996467 A NO 996467A NO 996467 A NO996467 A NO 996467A NO 996467 D0 NO996467 D0 NO 996467D0
Authority
NO
Norway
Prior art keywords
thiazofurine
nucleosides
preparation
Prior art date
Application number
NO996467A
Other languages
English (en)
Other versions
NO996467L (no
Inventor
Kandasamy Ramasamy
Rajanikanth Bandaru
Devron Averett
Original Assignee
Icn Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icn Pharmaceuticals filed Critical Icn Pharmaceuticals
Publication of NO996467D0 publication Critical patent/NO996467D0/no
Publication of NO996467L publication Critical patent/NO996467L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/24Heterocyclic radicals containing oxygen or sulfur as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO996467A 1997-06-30 1999-12-23 FremgangsmÕte for fremstilling av tiazofurin og andre C- nukleosider NO996467L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5119197P 1997-06-30 1997-06-30
PCT/US1998/013367 WO1999000399A1 (en) 1997-06-30 1998-06-25 Method of producing tiazofurin and other c-nucleosides

Publications (2)

Publication Number Publication Date
NO996467D0 true NO996467D0 (no) 1999-12-23
NO996467L NO996467L (no) 2000-02-23

Family

ID=21969870

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996467A NO996467L (no) 1997-06-30 1999-12-23 FremgangsmÕte for fremstilling av tiazofurin og andre C- nukleosider

Country Status (19)

Country Link
US (1) US6613896B1 (no)
EP (1) EP1000075A4 (no)
JP (1) JP2002501546A (no)
KR (1) KR100540853B1 (no)
CN (1) CN1261370A (no)
AU (1) AU735601B2 (no)
BR (1) BR9810364A (no)
CA (1) CA2290364A1 (no)
HU (1) HUP0002389A3 (no)
IL (1) IL132737A0 (no)
NO (1) NO996467L (no)
NZ (1) NZ500831A (no)
PL (1) PL191173B1 (no)
RU (1) RU2185385C2 (no)
SI (1) SI20161A (no)
SK (1) SK172399A3 (no)
UA (1) UA63956C2 (no)
WO (1) WO1999000399A1 (no)
YU (1) YU67099A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050182252A1 (en) 2004-02-13 2005-08-18 Reddy K. R. Novel 2'-C-methyl nucleoside derivatives
CN114404427A (zh) 2014-02-13 2022-04-29 配体药物公司 前药化合物及其用途
JP2017520545A (ja) 2014-07-02 2017-07-27 リガンド・ファーマシューティカルズ・インコーポレイテッド プロドラッグ化合物およびそれらの使用
CN111788196A (zh) 2018-01-09 2020-10-16 配体药物公司 缩醛化合物及其治疗用途
JP2021519334A (ja) 2018-03-26 2021-08-10 クリア クリーク バイオ, インコーポレイテッド ジヒドロオロト酸デヒドロゲナーゼを阻害するための組成物および方法
US12030903B2 (en) 2020-02-18 2024-07-09 Gilead Sciences, Inc. Antiviral compounds
TWI794742B (zh) 2020-02-18 2023-03-01 美商基利科學股份有限公司 抗病毒化合物
JP2024512771A (ja) 2021-04-16 2024-03-19 ギリアード サイエンシーズ, インコーポレイテッド アミドを使用してカルバヌクレオシドを調製する方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451648A (en) * 1981-08-19 1984-05-29 The United States Of America As Represented By The Department Of Health And Human Services Process for the production of 2-β-D-ribofuranosylthiazole-4-carboxamide
US4531001A (en) * 1982-03-23 1985-07-23 Brigham Young University 2-β-D-ribofuranosylselenazole-4-carboxamide compounds
US4619996A (en) * 1984-07-09 1986-10-28 Warner-Lambert Company Process for preparing 2-β-D-ribofuranosylselenazole-4-carboxamide
US5907036A (en) * 1995-02-17 1999-05-25 Icn Pharmaceuticals, Inc. Procedures for obtaining ribo-C-nucleosides
DE69721339T2 (de) * 1996-10-16 2004-01-22 Ribapharm, Inc., Costa Mesa Monozyklische l-nukleoside, analoga und ihre anwendungen

Also Published As

Publication number Publication date
IL132737A0 (en) 2001-03-19
US6613896B1 (en) 2003-09-02
SK172399A3 (en) 2000-07-11
RU2185385C2 (ru) 2002-07-20
HUP0002389A2 (hu) 2001-08-28
PL191173B1 (pl) 2006-03-31
UA63956C2 (uk) 2004-02-16
JP2002501546A (ja) 2002-01-15
NZ500831A (en) 2001-06-29
EP1000075A4 (en) 2001-09-05
CA2290364A1 (en) 1999-01-07
CN1261370A (zh) 2000-07-26
EP1000075A1 (en) 2000-05-17
YU67099A (sh) 2002-06-19
WO1999000399A1 (en) 1999-01-07
KR20010039514A (ko) 2001-05-15
AU8268898A (en) 1999-01-19
SI20161A (sl) 2000-08-31
HUP0002389A3 (en) 2002-04-29
NO996467L (no) 2000-02-23
KR100540853B1 (ko) 2006-01-10
PL337716A1 (en) 2000-08-28
WO1999000399A9 (en) 1999-04-15
BR9810364A (pt) 2000-09-05
AU735601B2 (en) 2001-07-12

Similar Documents

Publication Publication Date Title
NO970444D0 (no) Fremgangsmåte for fremstilling av metaller og andre elementer
NO962179D0 (no) Fremgangsmåte for fremstilling av metallocen og anvendelse derav
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO20012963L (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
NO20015542L (no) Fremgangsmåte for fremstilling og anvendelse av N- desmetylzopikloner
DK0805797T3 (da) Fremgangsmåde til fremstilling af N-aryl- og N-hetarylhydroxylaminer
NO20002174D0 (no) FremgangsmÕte for fremstilling av tiazolidindion-derivater
NO996467L (no) FremgangsmÕte for fremstilling av tiazofurin og andre C- nukleosider
NO994505L (no) Forbedret fremgangsmåte for fremstilling av tiazolidindioner og nye tiazolidindioner
NO993949L (no) FremgangsmÕte for fremstilling av substituert tiazolidindion
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO304110B1 (no) FremgangsmÕte for fremstilling av glutardialdehyd
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
NO20003145D0 (no) FremgangsmÕte for fremstilling av paroxetine-hydroklorid
ITBZ950045A0 (it) Gioiello e procedimento per la realizzazione dello stesso.
NO972682D0 (no) Ny fremgangsmåte for fremstilling av sameridin
NO20003077L (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
NO961577L (no) Fremgangsmåte for fremstilling av tre-polymer-kompositter
NO982975D0 (no) FremgangsmÕte for fremstilling av fosfatbundne keramer
NO990185D0 (no) FremgangsmÕte for fremstilling av naftypyridoner og mellomprodukter
FI970269A (fi) 1,3-diolipohjaisten esterien seokset, menetelmä 1,3-diolipohjaisten esterien valmistamiseksi sekä esterien käyttö
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application